Blockchain analytics firm TRM Labs secures major funding led by Blockchain Capital and Goldman Sachs, reaching unicorn status as governments and financial institutions increasingly rely on its tools to track illicit crypto transactions.
The Department of Justice is under fire for its handling of the court-ordered release of documents related to Jeffrey Epstein, with critics pointing to significant delays, improper redactions that exposed victims' identities, and the publication of explicit images. Officials defend the process as legally compliant.
A temporary spending bill ends a brief government shutdown, while a would-be assassin of former President Trump faces sentencing. Other headlines include murder charges for Jill Biden's ex-husband, renewed US-Iran nuclear talks, and a sharp decline in Bitcoin's value.
While the biosimulation leader reports rising revenues and capital investment, its key profitability metric—Return on Capital Employed—has declined to 2.2%, significantly trailing the healthcare services sector. Analysts question whether current growth investments will translate into future shareholder value.
Despite headwinds in the smartphone market, Bernstein remains constructive on Qualcomm (QCOM), citing its valuation discount, high-end market positioning, and growing AI narrative as key drivers for future performance.
While Veeva Systems continues to invest heavily in its future, a five-year slide in its return on capital employed (ROCE) signals potential headwinds for the life sciences cloud giant. We examine whether the current growth-at-all-costs strategy will pay off for long-term shareholders.
A new discounted cash flow analysis suggests Alnylam Pharmaceuticals (ALNY) shares trade at a significant discount to their intrinsic value, presenting a potential opportunity for investors. However, experts caution that valuation is just one piece of the investment puzzle.
A wave of insider stock sales at Symbotic Inc. over the past year, including a multi-million dollar divestment, is prompting scrutiny from market watchers. While insider selling alone isn't a definitive sell signal, the absence of any insider buying during this period adds a layer of concern for shareholders evaluating the high-flying automation stock.
Skeena Resources has received the final Environmental Management Act permit for its Eskay Creek gold-silver project in British Columbia, completing the regulatory process and setting the stage for mining to resume in Q2 2027 following a collaborative approval with Indigenous partners.
As Pi (PI) trades 94% below its peak, the project's core team executed a massive internal transfer of 500 million tokens in early February. This move coincides with a record monthly unlock of over 193 million Pi, creating a critical test for the struggling network's ecosystem and investor sentiment.
A new report from the influential CfC St. Moritz conference reveals a significant cooling in enthusiasm for crypto IPOs among wealthy investors and executives. While some activity is expected in 2026, confidence has dipped from last year's peak, with attention turning to liquidity, regulation, and market consolidation.
New research exposes a systemic flaw in cryptocurrency media, finding that most press releases distributed through specialized wires promote dubious projects, blurring the lines between news and unvetted marketing.
A wave of Israeli airstrikes across Gaza on Wednesday shattered the fragile U.S.-brokered truce, killing at least 19 Palestinians, including infants, and drawing sharp condemnation from local health officials who question the ceasefire's viability.
Amid elevated market valuations, investors with limited capital can still find compelling opportunities. We examine three companies with strong growth trajectories and attractive entry points.
As data center electricity demand is set to double by 2030, established energy providers like Dominion Energy are emerging as critical, lower-volatility beneficiaries of the artificial intelligence revolution.
Medtronic has exercised its option to acquire CathWorks, the developer of the AI-powered FFRangio System, in a deal valued at $585 million. The acquisition, pending regulatory approval, aims to accelerate the transformation of coronary artery disease diagnosis and solidify Medtronic's position in the digital cath lab.
Novo Nordisk stock plummeted nearly 17% following a stark forecast predicting a significant drop in 2026 sales and profit, driven by intense U.S. price pressures and rising competition in the lucrative GLP-1 drug market.
Fueled by soaring demand for its data center and AI processors, AMD posts historic Q4 and full-year 2025 results. The chipmaker also used CES 2026 to showcase new platforms aimed at capturing a larger share of the booming enterprise AI market.
While artificial intelligence reshapes the entry-level landscape, new data reveals that advanced degrees in human-centric fields like mental health counseling and law are not only resilient but experiencing surging demand, offering a clear path for graduates navigating economic uncertainty.
A generation of Venezuelan energy experts who fled political turmoil and helped build Canada's oil sands industry now see their future firmly rooted in their adopted country, despite recent geopolitical shifts aimed at reviving Venezuela's oil sector.
